629 Neoadjuvant SEMA4D inhibitor pepinemab combination with nivolumab increases crosstalk between B cell and CD26hi T cell in patients with resectable stage III melanoma
Ayana T Ruffin, Brian Olson, Crystal Mallow, Christine Reilly, Jacklyn Hammons, Jayden Kim, Brian Burns, Agnes Harutyunyan, Elizabeth Evans, Terrence Fisher, Maurice Zauderer, Keith A Delman, Melinda Yushak, Ali Mokhtari, Douglas Parker, Ragini Kudchadkar, Chrystal M Paulos, Gregory B Lesinski, Michael C Lowe
Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A718; DOI: 10.1136/jitc-2023-SITC2023.0629